Lexicon Pharmaceuticals LXRX reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Lexicon Pharmaceuticals reported in-line EPS of $-0.16 versus an estimate of $-0.16.
Revenue was down $199 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 2.7% drop in the share price the next day.
To track all earnings releases for Lexicon Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.